Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
27 hedge funds and large institutions have $3.49M invested in Acer Therapeutics Inc in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 9 closing their positions.
16% less funds holding
Funds holding: 32 → 27 (-5)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
43% less capital invested
Capital invested by funds: $6.14M → $3.49M (-$2.66M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
92% less call options, than puts
Call options by funds: $2K | Put options by funds: $24K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$4.35M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 3 |
Renaissance Technologies
New York
|
+$105K |
| 4 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
+$68.1K |
| 5 |
Two Sigma Investments
New York
|
+$35.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DMKJ
David M. Knott Jr
|
-$351K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$49.6K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$45.5K |
| 4 |
BlackRock
New York
|
-$31.7K |
| 5 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$28.9K |
ACER Hedge Fund Activity: Q1 2023 in Review
27 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2023, worth a combined $3.49M — down 43% from $6.14M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ACER and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $4.35M. The largest seller was David M. Knott Jr, exiting entirely with an estimated $351K sold.
- 27 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2023, down from 32 in Q4 2022.
- Funds reported $3.49M of Acer Therapeutics Inc stock for Q1 2023, down 43% quarter-over-quarter.
- 5 funds opened new Acer Therapeutics Inc positions in Q1 2023 and 9 closed out, a net change of -4 holders.
- The largest Acer Therapeutics Inc buyer in Q1 2023 was Armistice Capital, an estimated $4.35M added.
- The largest Acer Therapeutics Inc seller in Q1 2023 was David M. Knott Jr, an estimated $351K sold.
Based on aggregated 13F filings for Q1 2023.